Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,060 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours.
Brana I, Berger R, Golan T, Haluska P, Edenfield J, Fiorica J, Stephenson J, Martin LP, Westin S, Hanjani P, Jones MB, Almhanna K, Wenham RM, Sullivan DM, Dalton WS, Gunchenko A, Cheng JD, Siu LL, Gray JE. Brana I, et al. Among authors: berger r. Br J Cancer. 2014 Nov 11;111(10):1932-44. doi: 10.1038/bjc.2014.497. Epub 2014 Oct 7. Br J Cancer. 2014. PMID: 25290091 Free PMC article. Clinical Trial.
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.
Antonarakis ES, Piulats JM, Gross-Goupil M, Goh J, Ojamaa K, Hoimes CJ, Vaishampayan U, Berger R, Sezer A, Alanko T, de Wit R, Li C, Omlin A, Procopio G, Fukasawa S, Tabata KI, Park SH, Feyerabend S, Drake CG, Wu H, Qiu P, Kim J, Poehlein C, de Bono JS. Antonarakis ES, et al. Among authors: berger r. J Clin Oncol. 2020 Feb 10;38(5):395-405. doi: 10.1200/JCO.19.01638. Epub 2019 Nov 27. J Clin Oncol. 2020. PMID: 31774688 Free PMC article. Clinical Trial.
Avelumab + axitinib vs sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase 3 JAVELIN Renal 101 trial.
Choueiri TK, Penkov K, Uemura H, Campbell MT, Pal S, Kollmannsberger C, Lee JL, Venugopal B, van den Eertwegh AJM, Negrier S, Gurney H, Albiges L, Berger R, Haanen JBAG, Oyervides Juárez V, Rini BI, Larkin J, Nolè F, Schmidinger M, Atkins MB, Tomita Y, Ellers-Lenz B, Hoffman J, Sandner R, Wang J, di Pietro A, Motzer RJ. Choueiri TK, et al. Among authors: berger r. Ann Oncol. 2024 Dec 18:S0923-7534(24)04987-1. doi: 10.1016/j.annonc.2024.12.008. Online ahead of print. Ann Oncol. 2024. PMID: 39706335 Free article.
Curriculum interventional cardiology-Austria.
Kammerlander A, Berger R, Binder RK, Dörler J, Frick M, Gremmel T, Mader A, Kammler J, Rab A, Geppert A, Schober A, Niessner A. Kammerlander A, et al. Among authors: berger r. Wien Klin Wochenschr. 2024 Dec;136(Suppl 19):725-731. doi: 10.1007/s00508-024-02475-6. Epub 2024 Dec 16. Wien Klin Wochenschr. 2024. PMID: 39681730 Free PMC article.
Age- and sex-specific reference percentile curves for accelerometry-measured physical activity in healthy European children and adolescents.
Ploegstra MJ, Swenne A, Buck C, Moreno LA, Lissner L, Lauria F, de Henauw S, Molnár D, Tornaritis M, Konstabel K, Rayson M, Pitsiladis Y, Manios Y, Béghin L, Widhalm K, Polito A, Sinningen K, Kafatos A, Gomez-Martinez S, González-Gross M, Casajús JA, Mazur A, Ortega FB, Ahrens W, Berger RMF, Intemann T. Ploegstra MJ, et al. Among authors: berger rmf. Eur J Pediatr. 2024 Dec 5;184(1):65. doi: 10.1007/s00431-024-05902-y. Eur J Pediatr. 2024. PMID: 39636324
4,060 results